Chemical Compound

(1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl; Lovastatin Imp. C (EP); Dehydrolovastatin; Lovastatin Impurity C

CAS Registry Number 109273-98-5
(1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl; Lovastatin Imp. C (EP); Dehydrolovastatin; Lovastatin Impurity C 结构式
Primary record

(1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl; Lovastatin Imp. C (EP); Dehydrolovastatin; Lovastatin Impurity C

库存
4,730 克
纯度
99.4 %
CAS
109273-98-5

化合物标识与属性

CAS
109273-98-5
PubChem CID
71315317
SMILES
CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3CC=CC(=O)O3)C
Canonical SMILES
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3CC=CC(=O)O3)[C@H]21

名称与同义词

  • Dehydro Lovastatin
  • Dehydromonacolin K
  • Anhydrolovastatin
  • Dehydrolovastatin
  • Lovastatin EP Impurity C
  • 109273-98-5
  • |A,|A-Dehydrolovastatin
  • 2BW5MV3UB3
  • Dehydrolovastatin [EP]
  • starbld0027803
  • RefChem:1083071
  • UNII-2BW5MV3UB3
  • alpha,beta-dehydrolovastatin
  • Lovastatin impurity C [EP]
  • DTXSID40747447
  • CHEMBL3946905
  • SCHEMBL30429165
  • DTXCID30698191
  • C24H34O4
  • MSK10321
  • ZINC65739660
  • DEHYDROLOVASTATIN [EP IMPURITY]
  • .ALPHA.,.BETA.-DEHYDROLOVASTATIN
  • L 642257
  • Dehydrolovastatin 100 microg/mL in Acetonitrile
  • LOVASTATIN IMPURITY C [EP IMPURITY]
  • FT-0665620
  • J1.095.558K
  • [(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
  • (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-(2-((2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
  • (S)-(1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-(2-((R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate
  • (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl (2S)-2-Methylbutanoate (Dehydrolovastatin)
  • (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-{2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl}-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
  • Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-8-(2-((2R)-3,6-dihydro-6-oxo-2H-pyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenyl ester, (2S)-
  • ((1S,3R,7S,8S,8aR)-3,7-dimethyl-8-(2-((2R)-6-oxo-2,3-dihydropyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2R)-2-methylbutanoate
  • (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl; Lovastatin Imp. C (EP); Dehydrolovastatin; Lovastatin Impurity C
  • (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8ahexahydronaphthalen-1-yl (2S)-2-methylbutanoate
  • (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-{2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl}-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2S)-2-methylbutanoate
  • (2S)-2-Methylbutanoic Acid (1S,3R,7S,8S,8aR)-8-[2-[(2R)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenyl Ester
  • (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalene-1-yl ester
  • (2S)-2-Methylbutyric acid (1S)-1,2,3,7,8,8aalpha-hexahydro-3beta,7alpha-dimethyl-8alpha-[2-[[(2R)-3,6-dihydro-6-oxo-2H-pyran]-2-yl]ethyl]naphthalene-1beta-yl ester